About this document
Hatch-Waxman Act and Generic Drugs Review by Gaming Viper is a document available to read on EtoBox.
This document provides a review of the Hatch-Waxman Act and how it supports the availability of lower-cost generic drugs. The Act established an abbreviated new drug application process that allows generic drug manufacturers to develop generic versions of brand-name drugs before the original patent expires. This enables generics to enter the market sooner. The Act also provides patent term extensions for brand drugs to compensate for time lost during regulatory review. The review describes the four types of
- Author
- Gaming Viper
- Language
- EN